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ABSTRACT 
Autism spectrum disorder (ASD) is a neurological disorder characterized by decreased 
sociability, deficits in communication, and restricted and repetitive behaviors. The 
ketogenic diet (KD), a high-fat, low-carbohydrate, and moderate-protein diet has been 
shown to improve these three behavioral symptoms in the BTBR mouse model of autism. 
However, further research is required to strengthen the body of knowledge surrounding 
the potential of KD as diet therapy for autism. Epidemiological observations have shown 
that maternal immune activation (MIA) during pregnancy increases the risk of autism in 
offspring. Based on these observations, the polyinosinic:polycytidylic acid (poly(IC)) mouse 
model was developed as an animal model to study autism. Poly(IC) is a synthetic analog of 
double stranded RNA and acts as a viral mimic. It is injected into a pregnant dam, activating 
an immune response without causing an infection. The offspring of this protocol are the 
poly(IC) MIA mouse model. They have been shown to have the autistic symptoms of deficits 
in sociability and communication as well as increased repetitive behaviors. In this study, 
pregnant dams were injected with poly(IC) or the saline vehicle during the late first 
trimester. The offspring were separated into control and test groups. At 5 weeks of age, the 
test group was placed on a 6:1 fat:(carbohydrates + protein) KD while the control groups 
remained on standard chow. After three weeks on the diet, we assessed sociability, 
repetitive behavior, and communication. Our results showed that KD reversed increased 
self-grooming in poly(IC) mice. Results did not indicate autistic-like behavior in our 
poly(IC) mice for social contact, sociability, grooming during the 3-chamber test, or 
repetitive behavior in the marble-burying test. However, KD increased social contact in 
poly(IC) mice. It also increased sociability and decreased 3-chamber grooming in poly(IC) 
males. Poly(IC) mice did not have a deficit in the social transmission of food preference 
task, a previously unused assessment of the poly(IC) mouse model. While our study did not 
succeed in replicating several autistic behaviors in the poly(IC) mouse model, KD had 
influence on behavior in multiple measures, increasing sociability and decreasing 
grooming. This suggests that KD may be an effective diet therapy for autism.  
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INTRODUCTION 
AUTISM SPECTRUM DISORDER DEFINITION & DIAGNOSIS 
Autism spectrum disorders (ASD) are a heterogeneous group of 
neurodevelopmental disorders characterized by deficits in social communication and 
interaction as well as repetitive and restricted behaviors. While instances of ASD are often 
referred to simply as autism, these disorders incorporate a wide range of symptoms which 
additionally can range from mild to severe. ASD includes multiple disorders such as autism, 
Asperger syndrome, childhood disintegrative disorder, and pervasive developmental 
disorders-not otherwise specified (PDD-NOS) (Kim & Lord, 2013).  
Diagnostic criteria in the Diagnostic and Statistical Manual of Mental Disorders 
(DSM V) of the American Psychiatric Association (APA) currently include the presentation 
of social communication and interaction impairments and repetitive and restricted 
behaviors in early development. Diagnosis generally occurs on average around 4 years of 
age and is still entirely behaviorally based as there are currently no reliable biological 
markers for autism (Kim & Lord, 2013). Later in life, these symptoms cause significant 
impairment in the social or occupational life of the patient (APA, 2013). Other symptoms 
can include intellectual, language, sensory, and motor impairments (Kim & Lord, 2013). 
IMPACT & PREVALENCE OF ASD 
 ASD can severely compromise the quality of life in children and adults with the 
disorder. Their behaviors—which can include complex rituals, tantrums, and even self-
injury—can be highly disruptive to daily life. The detriment to relationships, school, and 
employment can have lasting effects on the life trajectory of autistic individuals. Patients 
often do not achieve full independence (Lee et al., 2008). Medical expenditures for autistic 
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children are significantly higher than they are for their healthy peers. The lifetime cost of 
autism was estimated in 2007 to be $3.2 million (Ganz, 2007). In the UK, the public cost of 
supporting children was estimated in 2009 to be £2.7 billion annually and, for adults, £25 
billion (Knapp et al., 2009). 
The Centers for Disease Control and Prevention reported that the overall prevalence 
of ASD in 2010 was estimated to be about 1 in 68 among 8 year olds in the United States. 
This has increased from a rate of 1 in 110 in 2006. In the past 40 to 50 years it has been 
estimated that rates of autism have increased by at least a factor of 20. The ratio of ASD 
diagnosis differs significantly between the sexes at a ratio of approximately 4.5 males to 1 
female. The factors leading to the increase in rates of autism are unclear and likely 
multifactorial, including greater capabilities of detection, heightened awareness, and an 
increase in risk factors or etiology (CDC, 2014; Currenti, 2010). Interestingly, 3-25% of 
individuals eventually lose their ASD diagnosis. Different types of ASD or inaccurate 
diagnosis could explain these findings. Additionally, effective treatment may maximize the 
likelihood of children achieving this optimal outcome (Helt et al., 2008; Fein et al., 2013). 
TREATMENT OF ASD 
Unfortunately, there is no cure for ASD and the treatments for the disorders are 
limited. The most effective treatment options for ASD include the combination of 
educational programming and behavioral intervention. In this treatment, patients undergo 
training for speech, language, social skills, and behavior. Ideally such therapy and education 
begins as early as possible. Such treatment requires frequent intensive sessions with 
trained professionals, making it very expensive and time-consuming. Additional treatment 
options include addressing the non-core symptoms of ASD such as motor therapy for motor 
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deficits and risperidone or aripiprazole for irritability, as well as medications for 
inattention, hyperactivity, sleep problems, anxiety, mood, and aggression (Lofthouse et al., 
2012). Treating comorbidities such as seizures, gastrointestinal, metabolic, and hormonal 
disorders can also help a patient (Bauman, 2014). However, medications for these 
symptoms are often less effective for children with ASD than they are for those without and 
they often come with serious side effects. Other complementary and alternative treatments 
include diet intervention, meditation, therapy animals, chelation therapy and music 
therapy. But many of these treatments are still unsubstantiated (Lofthouse et al., 2012; 
Matson et al., 2013). 
NEUROANATOMY & ETIOLOGY OF ASD 
 There are currently no consistent neuroanatomical pathologies confirmed for ASD. 
However, the characteristic symptoms of ASD suggest involvement of the frontal lobe, 
superior temporal cortex, the parietal cortex, amygdala, orbitofrontal cortex, caudate 
nucleus, and language cortices (Amaral et al., 2008). Various structures have been 
implicated in postmortem and structural magnetic resonance imaging. Differences have 
been seen in the volume of the total brain, cerebral hemispheres, cerebellum, caudate 
nucleus, corpus callosum, and amygdala (Amaral et al., 2008; Stanfield et al., 2008). Overall, 
the brain of a child with ASD is enlarged relative to controls during early postnatal life and 
then growth decreases relative to controls in adolescence. Studies have suggested that the 
abnormal enlargement of the amygdala is correlated with heightened anxiety. However, 
these studies have been limited due to factors such as small sample size, comorbidities, and 
the inability to confirm diagnosis until 2-3 years of age (Amaral et al., 2008; Stanfield et al., 
2008).  
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The cause of autism is still largely unknown and no reliable biomarkers have been 
identified. ASD is likely a disorder resulting from a combination of genetic and 
environmental factors. ASD can be caused by known genetic syndromes, and this is the case 
for approximately 15% of instances of ASD and typically known as syndromic autism 
(Gabrucker, 2013). Fragile X syndrome, tuberous sclerosis, neurofibromatosis, untreated 
phenylketonuria, Angelman, Cornelia de Lange, and Down syndrome can all present 
autistic features. The most common of these are Fragile X syndrome and tuberous sclerosis 
which both increase protein synthesis (Laumonnier et al., 2004; Persico & Napolioni, 
2013). Autism is strongly associated with mutations in genes which encode for proteins 
that play a role in regulating synaptic protein synthesis (Persico & Napolioni, 2013). 
 Indeed, a cross-sectional study of 210 dizygotic twins and 67 monozygotic twins 
under the age of 18 revealed that rates of ASD concordance between dizygotic and 
monozygotic twins are 31% and 88%, respectively. The 4:1 male to female ratio of 
incidence suggests there is a sex-linked genetic influence. The possession of two X 
chromosomes may provide protection for females. Interestingly, all 9 pairs of female 
monozygotic twins in the study had a concordance of 100% while the 113 dizygotic twin 
pairs containing at least one female had a concordance of only 20% (Rosenberg et al., 
2009). Maternal environment during pregnancy is also considered a factor due to a higher 
concordance rate between dizygotic twins than between siblings (3-14%) (Sumi et al., 
2006). A study by Schwartzer et al. found that in mouse models of autism, prenatal 
exposure to maternal immune activation in genetic mouse models of autism exacerbated 
their autistic symptoms, further suggesting an interaction between genetic and 
environmental factors in the etiology of autism (2013). 
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MATERNAL ENVIRONMENT 
 Maternal environment is associated with a number of developmental neurological 
disabilities and disorders. Approximately 1 in 33 U.S. children are born with a birth defect. 
Only about 25% of these congenital abnormalities can be attributed to solely genetic 
causes. It is estimated that about 15% of developmental disorders are the result of 
environmental factors alone. The remaining 60% of disorders are multifactorial 
combinations of genetic and environmental causes or have currently unknown origins 
(Czeizel, 2005). 
In the case of ASD, there are a number of associated maternal environment risk 
factors. Abnormalities in fetal growth, whether above or below standard are associated 
with greater ASD risk (Abel, 2013). Furthermore, risk of ASD was decreased by 
approximately 40% in mothers who took prenatal supplements at least 4 times per week 
during the preconceptional window (3 – 1 months before conception) (Schmidt et al., 
2011). Taking valproic acid, an antiepileptic, during the prenatal period has been shown to 
increase risk of ASD behaviors in humans and animal models. (Engel & Daniels, 2011; 
Ornoy, 2009; Dean et al., 2002). Zinc deficiency, maternal diabetes, toxins, parental age, 
prenatal and perinatal stress, and prenatal infection are all events and situations currently 
recognized as environmental risk factors for ASD (Grabrucker, 2013). 
MATERNAL IMMUNE ACTIVATION AND ASD 
 Maternal infection has been associated with risks of various neurodevelopmental 
disorders, such as schizophrenia, autism, and cerebral palsy (Boksa, 2010). Evidence for 
the significance of prenatal infection on the risk of ASD is strong and growing. Prenatal 
viral infection exposure in the first trimester and bacterial infection in the second trimester 
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correlate with increased risk of ASD diagnosis in offspring (Atladottir et al., 2010). This 
effect has also been seen in animal models including mice, rats, and non-human primates 
(Boska, 2010; Bauman, 2014). Mothers with autistic children are more likely to have 
autoantibodies with negative effects on fetal brain development. It is suggested that these 
are transferred through the placenta to the offspring (Currenti, 2010). Mothers of autistic 
children are also more likely to have autoimmune diseases such as rheumatoid arthritis, 
celiac disease, and type 1 diabetes (Patterson, 2011). 
The mechanisms by which maternal immune activation (MIA) increases the risk of 
ASD is not fully understood, but it is likely multifactorial. Data suggests that this 
environmental factor combines with genetic risk factors. Indeed, there is an association 
between being born at the peak of the influenza season and having tuberous sclerosis with 
autistic behaviors (TSC-ASD) while there is no such association between date of birth and 
TSC alone (Patterson, 2011). The multiple neurobiological effects MIA has on animal 
models may help to explain its mechanisms of action. MIA has been shown to increase 
circulating interleukin-6 (IL6) and placental cytokines. It is known to lead to oxidative 
stress, morphological changes in the brain, and changes in neurotransmitter systems 
(Boksa, 2010; Patterson, 2011). 
IMMUNE DYSFUNCTION & INFLAMMATION 
 The influence of MIA is likely connected to the data showing immune dysfunction 
and inflammation in individuals with ASD. The association between ASD and immune 
dysfunction and inflammation is the most strongly supported correlations between ASD 
and a physiological abnormality (Rossignol & Frye, 2012). This relationship is shown in 
many ways. The immune system of autistic individuals is often abnormal. Families with 
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autism are more likely to have autoimmune disorders (Croen et al., 2005). Autistic children 
show serum antibody reactivity against human cortical and cerebellar brain regions 
(Currenti, 2010). An inflammatory-like state was found in postmortem autism brains: there 
were elevated cytokines and activated microglia and astrocytes throughout subjects 
ranging in age from 5 to 44 years, indicating that these changes occur early and are likely 
permanent (Vargas et al., 2005). Similarly, raised cytokines were also found in the 
cerebrospinal fluid of living autistic children (Chez et al., 2007). Additionally, autistic 
subjects have elevated plasma cytokines and chemokines; the blood brain barrier is 
permeable to these pro-inflammatory mediators (Ashwood, et al., 2011; Li et al., 2009). 
Inflammation in the gastrointestinal tract has also been indicated, perhaps contributing to 
the comorbidity between autism and gastrointestinal problems. Furthermore, microarray 
studies of autistic brains have shown that there is dysregulation of genes relating to 
immune function (Patterson, 2011).  
 The interaction between immune dysfunction/inflammation and ASD is not fully 
understood. Genetic susceptibility to immune-related disorders could alter brain function. 
However, altered brain morphology could also interfere with immune function, making this 
dysregulation a symptom rather than a cause. Some genes considered in the etiology of 
autism regulate both brain and immune development. Such genes include macrophage 
migration inhibitory factor (MIF), MET encoding tyrosine kinase, the reelin gene (RELN) 
and the human leukocyte antigen (HLA) genes (Careaga et al., 2012).   
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POLY(IC) MOUSE MODEL 
 In order to further investigate MIA as a risk for autism, research has developed MIA 
animal models of autism. Many animal modeling studies have shown that acute and lasting 
changes to behavior and CNS structure and function can be caused by prenatal immune 
activation. These studies, however, have varied regarding the materials, species, methods, 
and measurements used (Boksa, 2010). Both rodent and non-human primate models have 
exhibited abnormal, ASD-like behavior as a result of MIA (Boska, 2010; Bauman, 2014). 
Agents used for creating prenatal immune activation can cause an antiviral response, such 
as in the case of polyinosinic:polycytidylic acid (poly(IC)), or they can cause an 
antibacterial response, such as in the case of lipopolysaccharide (LPS) (Patterson, 2011).  
 This thesis investigated the effectiveness of dietary treatment for ASD using the 
poly(IC) mouse model. Offspring of dams injected with poly(IC) have been found to exhibit 
the core deficits of autism: decreased social and communicative behavior as well as 
increased repetitive and stereotyped behavior (Malkova et al., 2012). The mechanism by 
which poly(IC) has this effect has been explored. Poly(IC) mimics the structure of dsRNA 
that results from viral replication. It binds to the Toll-like receptors, dsRNA-activated 
protein kinase, and other proteins, activating an immune response and a cellular danger 
response. Poly(IC) inhibits translation of cap-dependent mRNAs and stimulates IL1β, IL6, 
TNFα, type I interferons (IFN) alpha and beta. Exposure to poly(IC) produces an observable 
response of initial fever followed by hypothermia as well as weight loss and reduced 
activity, food intake, and water intake. Recovery occurs approximately 24 hours after 
exposure (Naviaux et al., 2013; Traynor et al., 2004). 
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 In addition to increasing cytokines and chemokines, poly(IC) also leads to deficits in 
the mitochondrial function of leucocytes. Adult offspring had significant decreases in 
mitochondrial ATP production (Arrode-Bruses & Bruses, 2012; Giulivi, 2013). This 
significant difference in metabolic function suggests that diet therapy may be an effective 
treatment for the poly(IC) model of ASD. 
KETOGENIC DIET AND ASD 
 The ketogenic diet (KD) is a restricted carbohydrate, sufficient protein, and high fat 
metabolic therapy. KD has been used effectively as a diet therapy for epilepsy since the 
1920s, with an average of 43% of children and adults reaching greater than or equal to a 
50% seizure reduction (Payne, 2011). It has been shown to have various beneficial effects 
for many neurological diseases, including headache, neurotrauma, Alzheimer's disease, 
Parkinson's disease, sleep disorders, brain cancer, pain, multiple sclerosis, and depression 
(Stafstrom & Rho, 2012). ASD and epilepsy are highly comorbid, and it is suggested that KD 
may be an effective therapy for ASD symptoms (Kim & Lord, 2013; Ruskin et al., 2013). 
Indeed, therapeutic effects of KD have been shown for autism (Ruskin et al., 2013). A 
BTBR mouse model, which exhibits impaired sociability and communication as well as 
increased repetitive and restricted behaviors, was fed a strict KD (6.6:1 fats:(carbohydrates 
+ proteins)). The diet alleviated all three of the core behavioral deficits (Ruskin et al., 
2013).The mechanisms by which KD has neuroprotective and therapeutic effects are not 
yet fully understood, but there are several properties of the diet that may provide 
explanation for its potential use with ASD. 
KD has anti-inflammatory properties which may relieve inflammation and 
inflammation-related symptoms in ASD (Yang & Chenge, 2010; Kim et al., 2007; Gasior, 
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2006; Cullingford, 2004). It also reduces thermal nociception in juvenile and adult rats 
(Ruskin et al., 2009). A suggested mechanism for this anti-inflammatory effect is that 
saturated fatty acids, the predominant energy fuel for a body on the ketogenic diet, 
contribute to the regulation of inflammatory response genes by activating toll-like 
receptors that activate nuclear factor-kappa B and cycloocygenase-2 (Forsythe et al., 2008). 
In a study examining a murine model of experimental autoimmune encephalomyelitis, KD 
decreased inflammatory cytokines and chemokines while also improving motor disability, 
spatial learning and memory, and long-term potentiation in the CA1 hippocampus region 
(Hao et al., 2012).  
 The influence of the ketogenic diet on metabolism is also likely key for the beneficial 
effects of the diet. Metabolic disorders are common in autism. Mitochondrial electron 
transport chain complexes have decreased expression in the cerebellum and frontal and 
temporal regions in children with autism, likely contributing to abnormal metabolism and 
oxidative stress (Chauan et al., 2011). KD switches the body's energy source from glucose 
to ketones, fundamentally altering metabolism. 
 One suggested metabolic mechanism by which the ketogenic diet may be effective is 
through adenosine. Adenosine is a neuromodulatory purine that acts as a sleep modulator 
and anticonvulsant and is a core component of ATP (Masino et al., 2011). Additionally, 
adenosine kinase inhibitor and adenosine deaminase inhibitor have antinociceptive and 
anti-inflammatory effects (Poon & Sawynok, 1999). Those with ASD, as previously 
mentioned, often suffer from comorbidities of sleep disorders and epilepsy and ASD is 
highly associated with inflammation (Masino et al., 2011). Variants of adenosine A2A 
receptor gene have been associated with increases in autistic symptoms (Freitag et al., 
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2009). Additionally, autistic children have been reported to have reduced adenosine 
deaminase activity (Bottini et al., 2001). KD has been shown to increase ATP and adenosine 
in the brain (Nakazawa et al., 1983; Masino et al., 2009). Ketone bodies are increased while 
on the ketogenic diet. These ketone bodies substitute for glucose and are more efficient in 
ATP production (Masino et al., 2009). 
The present study will investigate the ability of the ketogenic diet to alleviate the 
autistic symptoms in the poly(IC) mouse model of ASD, further illuminating the therapeutic 
relevance of KD for ASD. 
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THESIS OVERVIEW 
The current study aims to investigate the effect of the ketogenic diet on the poly(IC) mouse 
model of autism in order to further the body of knowledge regarding the applications and 
efficacy of ketogenic diet therapy. Beneficial effects of the ketogenic diet were found 
previously in the BTBR strain of mice which, however, have an undefined genetic etiology 
of autism; therefore we chose to use this environmental model. It is hypothesized that the 
ketogenic diet will relieve autistic behaviors within the poly(IC) mouse model. 
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MATERIALS AND METHODS 
ETHICS STATEMENT 
All procedures were performed in accordance with the NIH Guide for the Care and 
Use of Laboratory Animals, and approved by the Animal Care and Use Committee of Trinity 
College (A3869-01). 
ANIMALS 
Adult female C57Bl/6 mice (Jackson Laboratories, Bar Harbor, ME) were 
determined to be "proven breeders" after having one or more previously successful litters. 
These breeders were housed socially with same-sex cage mates. Estrous cycle was visually 
monitored daily for each mouse. When a breeder was determined to be in proestrus/estrus 
phase, she was housed overnight with an adult male C57Bl/6 mouse. The following 
morning, the female mouse was checked for the presence of a vaginal plug, which marked 
embryonic day 0.5 (E0.5). Pregnant females were housed socially and not disturbed except 
for weekly cage cleaning.  
On day E10.5, dams were weighed and assigned to either the poly(IC) or saline 
injection group. Injections of 5mg/kg poly(IC) (potassium salt; P9582; Sigma, St. Louis, MO) 
or saline were administered intraperitoneally on days E10.5, E12.5, and E14.5. Poly(IC) 
was supplied by the manufacturer at 10% of the total weight of the salt, and the dosage was 
based on the weight of poly(IC) itself. All pups from each litter remained with the mother 
postnatal day 21 (P21), at which time they were weaned and housed socially with same-sex 
littermates. In the case of only one male or female pup in a litter, the pup was house socially 
with same-sex, same-age untreated C57 pups.  
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Between P21 and 5 weeks of age, all offspring were fed control diet (CD; LabDiet 
5001, W.F. Fisher & Son, Somerville, NJ). At 5 weeks of age, poly(IC) mice were separated 
into control and test groups and were either kept on CD or switched to KD (F3666; BioServ, 
Frenchtown, NJ), respectively. Mice of the saline-treatment group were kept on CD. A 
saline-treatment group on KD was not included because previous testing has shown KD has 
no significant effect on behavior in C57Bl/6 control mice (Ruskin et al., 2013). All testing 
occurred at 8-10 weeks of age at 3-5 weeks of dietary treatment. 
BEHAVIORAL TESTING 
SOCIABILITY 
 Sociability was testing using the three-chamber sociability test. A 22 x 42.5 x 19 cm 
Plexiglas box divided into three equal chambers was used. A 6 x 6 cm door in each of the 
internal walls allowed for free movement between the chambers. A small cylindrical wire 
cage (diameter 10.4 cm, height 11 cm, bar intervals 1 cm) was placed in both side 
chambers. Test subject mice were first habituated to the testing room for 30 minutes and 
then habituated to the central chamber for 10 minutes with the doors closed. Testing 
occurred in three 10 minute phases in which the test mouse was allowed to roam freely 
between chambers (Fig. 1). The test mouse was placed in the central chamber and the 
doors were lifted at the start of the phase. In the first phase, both wire cages were empty, 
allowing for a test of side bias. In phase two, a "stranger" mouse (C57Bl/6) was placed in 
the wire cage of one side chamber, allowing for a test of sociability. In the third phase a 
novel "stranger" mouse was placed in the other wire cage to allow for a test of preference 
for social novelty. The placement of the initial stranger mouse was counterbalanced 
between tests. Stranger mice were sex- and diet-matched to the test mouse, having started 
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Tests for side bias Tests for sociability 
preference 
Tests for social novelty 
preference 
the matched diet several days before testing to account for diet-related olfactory cues. In 
each phase, mice activity was video recorded and scored for time spent in each chamber 
and social contact (nose/face/forepaw contact with the cages and/or the stranger mice).  
 
 
 
 
 
 
Figure 1. Three-Chamber Test Paradigm. 
REPETITIVE & COMPULSIVE BEHAVIOR 
 Self-grooming was quantified in the three-chamber sociability testing and during a 
separate 10 minute test in order to measure self-directed repetitive behavior. In this test, 
the mouse was habituated to the room for 30 minutes and then habituated to the 
experimental polypropylene cage (19 x 29 x 12.5 cm) for 10 minutes. Mouse behavior was 
video recorded and quantified in a 10 minute phase following habituation. 
 Compulsive behavior was measured using the marble-burying test. Mice were 
allowed to habituate to the room for 30 minutes. An experimental polypropylene cage (19 x 
29 x 12.5 cm) was prepared with leveled 5 cm deep clean wood chip bedding (Betachip, 
Charles River). 15 black glass marbles (1.5 cm diameter) were evenly spaced in a 5 x 3 grid 
on top of the bedding. After habituation, the test mouse was placed in the experimental 
cage. After 30 minutes, the mouse was removed and returned to its home cage. A digital 
picture of the experimental cage was taken from above. Photoshop was used to count 
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marble pixels, using the "quick selection" tool, and to measure the bedding area, using the 
"polygonal lasso" tool. Marble pixels were expressed as a percent of the total bedding area 
pixels. A lower percentage of marble pixels is interpreted as indicating more burying and 
thus greater compulsive behavior. 
SOCIAL COMMUNICATION 
 Social communication was measured using the social transmission of food 
preference (STFP) test. Mice were habituated to eating KD or powdered CD, as appropriate, 
from clear glass jars (Dyets, Inc., Bethlehem, PA) 24 hours prior to the beginning of testing. 
The round jars had perforated lids, allowing for access to food and diminishing the 
displacement of food from mice digging. To begin the testing, a demonstrator mouse was 
removed from the home cage and placed in solitary housing. Both the demonstrator mouse 
and cage mates then fasted for 18 hours. A feeding jar containing a weighed amount of 
flavored powdered control diet food ("trained" flavor; 1% cinnamon or 2% cocoa) was 
presented to the demonstrator mouse and remained in the cage for 2 hours. If the 
demonstrator mouse had not yet eaten >0.5g of food, the diet was returned to the 
demonstrator. Once the demonstrator consumed >0.5g of food, it was returned to the home 
cage and allowed to interact with the cage-mate observer mice for 30 minutes. Observer 
mice were then separated into individual cages with a jar of the "trained" flavor and a jar of 
the "untrained" novel flavor. Jars were weighed before and after a 2 hour period in order to 
determine the preferred flavor. 
  
Figure 2. Social Transmission of Food Preference Test Paradigm.
BLOOD ANALYSIS 
 After the marble-burying test, blood glucose, ketone (beta
HB) levels were measures. Placed briefly in a plastic 
(Animal Health International), mice were anesthetized. Once unconscious, the mouse was 
removed and the tail vein was punctured with a razor blade. Blood was then analyzed for 
glucose and ketones using Precision Xtra meters 
were returned to their home cage to awake from anesthesia.
STATISTICAL ANALYSIS 
 Social and grooming behavior videos were scored by two independent researchers, 
at least one of whom was blind to treatment. Sociabili
sociability test was defined as the ratio of time spent in the "social" chamber to the total 
time spent in side chambers. Statistical analysis was conducting using student t
ANOVA with Newman-Keuls post
interaction effects. When sex differences were not found, data was collapsed across male 
and female mice. Outliers in each group during a given test were identified using Grubb’s 
outlier test and excluded from analys
<0.05 was considered significant.
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RESULTS 
Following 3-5 weeks on their respective diets, the saline-CD, poly(IC)-CD, and 
poly(IC)-KD groups underwent blood, weight, and behavioral testing in order to investigate 
the influence of KD on the autistic behaviors of the poly(IC) mouse model. 
BLOOD ANALYSIS 
Tail blood was collected under anesthesia to measure blood ketones and glucose 
levels. Poly(IC) mice fed KD had significant blood chemistry changes. For both male and 
female mice, ketone levels were significantly higher for the KD group compared to the CD 
groups (Fig. 3A). Within the poly(IC) groups, female mice had significantly higher ketone 
levels than their male counterparts (Fig. 3A). Mice fed KD also had significantly decreased 
glucose levels (Fig. 1B). There were no significant glucose differences between sexes. 
 
 
 
 
 
 
 
 
 
 
Figure 3. KD increases ketone levels and decreases glucose levels in poly(IC) mice. (A) shows ketone 
levels (mM) for both sexes in each treatment-diet condition. Levels were significantly higher for male and 
female poly(IC)-KD mice than male and female CD groups. Females in the poly(IC)-KD and poly(IC)-CD groups 
had significantly higher ketone levels than the males of their treatment-diet group. (saline-CD: male n=7, 
female n=15; poly(IC)-CD: male n=8, female n=12; poly(IC)-KD: male n=10, female n=11; *** p<0.001 
between groups, ### p<0.001 within group, # p<0.05) There was no significant condition x sex interaction. 
(B) shows glucose levels (mg/dL) in each treatment-diet condition. There were no significant sex differences, 
so data was collapsed. The poly(IC)-KD group had significantly lower glucose that the poly(IC)-CD and saline-
CD groups. (saline-CD: n=22; poly(IC)-CD: n=20; poly(IC)-KD: n=21; *** p<0.001).  
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WEIGHT 
At 5 and 8 weeks of age, female mice were weighed. As expected, the saline-CD and 
poly(IC)-CD groups gained significant weight during this 3 week time span. The poly(IC)-
KD females, however, did not significantly differ in weight between 3 weeks and 5 weeks of 
age. Additionally, they weighed significantly less than the CD groups (Fig. 4) 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 4. KD decreased weight gain. This figure weights at 3 weeks and 5 weeks of age for female mice in 
each treatment-diet condition. Saline-CD and poly(IC)-CD mice weighed significantly more at 8 weeks of age 
than at 5 weeks of age, while poly(IC)-CD mice did not differ in weight significantly between the two ages. 
Poly(IC)-CD mice weighed significantly less at 8 weeks of age than saline-CD and poly(IC)-CD mice. (saline-
CD: n=13; poly(IC)-CD: n=9; poly(IC)-KD: n=11; *** p<0.001 between groups, ### p<0.001 within group). 
Data were lost for the poly(IC)-CD male group, so male weight data is not presented.  
### 
*** 
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SOCIABILITY MEASURES 
SIDE CHAMBER TIMES 
Side chamber times in the 3-chamber test were used to assess sociability. Poly(IC)-
KD males spent significantly more time in the target chamber during phase 2 as compared 
both with their phase 1 scores and with the phase 2 times of both other groups. This 
demonstrates that poly(IC)-KD males had a preference for sociability while poly(IC)-CD 
and saline-CD males did not. No differences were found between the groups in the social 
novelty phase 3 (Fig. 5A). For females, however, no differences were found between the 
different groups. Each group showed significant preference for sociability in phase 2 and 
no preference for social novelty in phase 3 (Fig. 5B).  
 
 
 
 
 
 
 
 
 
 
 
Figure 5. KD increases male poly(IC) sociability during 3-chamber test. (A) shows time spent by male 
mice in the target chamber, which contained a stranger mouse (phase 2) or novel stranger mouse (phase 3), 
as a percentage of total time spent in side chambers. Male poly(IC)-KD mice spent significantly more time in 
the target chamber during phase 2 than during phase 1 and were significantly more social in phase 2 than 
both other groups. (males: saline-CD, n=7; poly(IC)-CD, n=8; poly(IC)-KD, n=8; ** p<0.01 between groups, ## 
p<0.01 within group). (B) shows time spent by female mice in the target chamber during the three-chamber 
test. No significant differences existed between groups. Each group spent significantly more time in the target 
chamber during phase 2 than in either phase 1 or 3. (females: saline-CD, n=12; poly(IC)-CD, n=12; poly(IC)-
KD, n=11; ### p<0.001 within group). 
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SOCIAL CONTACT 
Social contact made with the stranger mouse during the 3-chamber test was also 
used to assess sociability. Social contact data yielded different results than data of side 
chamber times. There were no significant differences between the sexes, so data were 
collapsed. Time spent by the test mouse making social contact with the target mouse was 
compared in phase 2 and phase 3. Poly(IC)-KD mice made significantly more social contact 
than either saline-CD or poly(IC)-CD mice. Similar to 3-chamber data, social contact made 
by saline- and poly(IC)-CD mice did not differ, demonstrating no deficit in either sociability 
measure for poly(IC) mice (Fig. 6). 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. KD increases social contact made by poly(IC) mice in 3-chamber test. Figure shows poly(IC)-
KD mice spent significantly more time making social contact with the target mouse's cage in phase 2 and 3 
than the other treatment-diet groups. (saline-CD, n=19; poly(IC)-CD, n=18; poly(IC)-KD, n=21; ***p<0.001).   
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REPETITIVE & COMPULSIVE BEHAVIOR MEASURES 
THREE-CHAMBER TEST GROOMING 
 Time spent self-grooming during phase 1 and 2 of the 3-chamber test was measured 
to assess self-directed repetitive behavior in a non-social and social setting. A treatment by 
sex interaction was found. Male saline-CD and poly(IC)-CD mice groomed significantly 
more in phase 2, the social phase, than in phase 1. Male poly(IC)-KD mice groomed 
significantly less in the social phase than saline-CD and poly(IC)-CD mice. Additionally, time 
spent grooming did not differ significantly between the social phase than the non-social 
phase (Fig. 7A). Each female group groomed significantly more in phase 2 than phase 1, 
although saline-CD mice showed the most distinct difference. In phase 2 female saline-CD 
mice groomed significantly more than poly(IC)-CD and poly(IC)-KD (Fig. 7B). 
 
 
 
 
 
 
 
 
 
 
Figure 7. KD lowered grooming in poly(IC) males in the social phase of Three-Chamber Test (A) shows 
time spent self-grooming by male mice during the 1st and 2nd phase of the three-chamber sociability test. 
Grooming differed significantly between phase 1 and 2 for saline-CD and poly(IC)-CD mice, but not poly(IC)-
KD mice. In phase 2 male poly(IC)-KD mice groomed significantly less than the other treatment-diet groups. 
(males: saline-CD, n=7; poly(IC)-CD, n=8; poly(IC)-KD, n=10; ### p<0.001 within group, *** <0.001 between 
groups). (B) shows time spent self-grooming by female mice during the 1st and 2nd phase of the three-
chamber test. Grooming differed significantly between phase 1 and 2 for each treatment-diet group. Female 
saline-CD mice groomed significantly more than the other groups in phase 2. (females: saline-CD, n=11; 
poly(IC)-CD, n=12; poly(IC)-KD, n=11; ### p<0.001 within group, # p<0.05).  
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Single Chamber Grooming 
SINGLE-CHAMBER GROOMING 
Single-chamber grooming was also measured to assess self-directed repetitive 
behaviors. Self-grooming while in a single-chamber was significantly higher for poly(IC)-CD 
mice compared to the saline and KD groups. Grooming time of the poly(IC)-KD mice did not 
significantly differ from grooming time of the saline-CD mice. Grooming was significantly 
increased in offspring by poly(IC) MIA. KD returned grooming to normal levels (Fig. 8). This 
supports a reversal of a poly(IC)-induced increase of self-grooming by KD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. KD reverses increased self-grooming in poly(IC) mice. Figure shows the total time spent self-
grooming by the test mouse while in a single chamber. Self-grooming while in a single-chamber was 
significantly higher for poly(IC)-CD mice compared to the saline and KD groups. Grooming time of the 
poly(IC)-KD mice did not significantly differ from grooming time of the saline-CD mice. (saline-CD, n=19; 
poly(IC)-CD, n=20; poly(IC)-KD, n=21; * p<0.05). 
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MARBLE-BURYING 
The extent of marble-burying performed by mice during a 30 minute phase was 
used to assess compulsive behavior. There were no significant differences between any of 
the groups (Fig. 9). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. No differences in marble burying between groups. The figure shows the amount of marble 
pixels visible as a % of the total number of pixels of bedding. The baseline bar shows the amount of marble 
visible in a test chamber before a mouse is introduced (n=10). No significant differences were found between 
groups. (saline-CD, n=18; poly(IC)-CD, n=17; poly(IC)-KD, n=21). 
 
SOCIAL COMMUNICATION MEASURES 
STFP was conducted to investigate communication. To the best of the author's knowledge, 
this measure has not been used on the poly(IC) mouse model before. Poly(IC)-CD mice ate 
significantly more of the trained flavor (0.60±.10g) than the untrained flavor (0.11±.04g) 
(n=12, p<0.01). Because no deficit was found in the poly(IC)-CD group, further analysis was 
not conducted. 
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DISCUSSION 
POLY(IC) MOUSE MODEL OF AUTISM 
In this study, blood, weight, and behavioral effects of KD on the poly(IC) mouse 
model of autism were assessed. As a model for autism, poly(IC) has been previously shown 
to exhibit core deficits of decreased social and communicative behavior as well as 
increased repetitive and stereotyped behavior (Malkova et al., 2012). However, analysis of 
our data showed an unexpected lack of abnormality in our poly(IC) for most behavioral 
measures. Within the 3-chamber test paradigm, poly(IC) mice did not differ significantly 
from saline controls for side preference times, social contact times, or grooming times. 
Furthermore, marble-burying and STFP measures did not indicate a clear deficit for our 
poly(IC) mice. At this time it is unclear if the lack of a difference between our poly(IC) and 
saline controls stems from a failure to develop poly(IC) offspring with the full range of 
autistic symptoms commonly attributed to them or if some abnormality was present in our 
saline controls, inhibiting proper analysis of our poly(IC) mice. 
SOCIABILITY 
Several other studies have used the 3-chamber paradigm for sociability and have 
found different results.  A 2012 study by Malkova and colleagues found poly(IC) mice to be 
significantly less social than their saline control counterparts (Malkova et al., 2012). 
Similarly, Naviaux et al. (2013), in the process of investigating antipurinergic therapy for 
autism features in the poly(IC) mouse, observed that poly(IC) mice were significantly less 
social in the 3-chamber paradigm both by the side preference and social contact measures. 
More recently, a study by Xuan & Hampson (2014) found that both males and female 
subjects had reduced sociability in the 3-chamber test. Each of these studies focused their 
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attention on the preference for sociability phase 2 portion of the 3-chamber test. 
Interestingly, what makes our results markedly different from those of these studies is the 
lack of a significant difference between the control and poly(IC) mice. Similar to other 
studies, our male poly(IC) mice were considerably anti-social in the second phase of our 3-
chamber sociability test, spending only approximately 40% of their time in the chamber 
with the stranger mouse. However, our saline controls also exhibited anti-social behavior, 
prohibiting us from characterizing the anti-social behavior of our poly(IC) mice as 
abnormal. 
The difference between male and female mice within our 3-chamber paradigm is 
not wholly unexpected as general literature is inconsistent regarding the severity of female 
poly(IC) deficits. While it is unclear why female saline controls would be significantly social 
in phase 2 while male saline mice were not, the lack of an anti-social characteristic in the 
poly(IC) females is in agreement with the study by Naviaux and colleagues (2013) which 
noted milder social abnormalities in their female poly(IC) mice. Other studies however 
have seen decreased sociability for both males and females (Xuan & Hampson, 2014; Shi et 
al., 2003; Schwartzer et al., 2013). Overall, there is a lack of research regarding female 
poly(IC) mice. 
Furthermore, the difference in results between the side preference and social 
contact measures is of interest and requires explanation. Within the 3-chamber test, side 
preference and social contact are both measures of sociability in the test mouse. Typically 
the results of each of these measures are similar. Other studies have found that social 
contact and chamber times are highly correlated; difference between them is mild or non-
significant, and the main difference between the two measures is that social contact is a 
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more sensitive measure of sociability (Silverman et al., 2012; Chadman, 2008; Nadler et al., 
2004). Therefore, the apparent difference between our chamber time and social contact 
data with regard to our female mice (which exhibited very different group effects in the 3-
chamber test but were collapsed across sex in the social contact measure) was unexpected. 
However, in our social contact data, there was a non-significant trend of sex effect (p=0.1) 
with the female saline-CD and poly(IC)-CD groups grooming more than their male peers. 
The difference of female data suggests that saline-CD and poly(IC)-CD mice spent 
significant time in the side chamber without making significant contact with the stranger 
mouse. 
REPETITIVE BEHAVIORS 
The measured levels of repetitive, stereotypical behaviors in our poly(IC) mice were 
inconsistent. The lack of deficit in the marble-burying protocol is also unexpected. The 
study by Malkova et al. found significantly increased marble burying in their male poly(IC) 
mice (2012). Xuan & Hampson found similar results for their male (but not female) mice, 
while Schwartzer et al. observed increased marble burying for both sexes (2014; 2013).  
Increased grooming in the single-chamber paradigm of our study showed a marked 
abnormality for poly(IC) mice. They groomed significantly more than saline controls, 
indicating an autistic-like increase in self-directed repetitive behavior. Malkova et al. found 
similar results while Xuan & Hampson did not detect a deficit in this measure. Grooming 
behavior in the 3-chamber paradigm adds further question to the autistic phenotype of our 
poly(IC) mouse model. Grooming times of poly(IC) mice in the first and second phase of the 
3-chamber paradigm is thus far poorly researched. Our data revealed significantly 
increased grooming in the social situation phase 2 for both saline and poly(IC) mice 
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compared to non-social situation phase 1. In female mice, the increase in grooming was far 
more pronounced in saline mice, which groomed significantly more than poly(IC) females 
in phase 2. Therefore, our data did not indicate that the poly(IC) had increased self-directed 
behavior in the social setting.  
The difference seen in data between grooming in the 3-chamber test and in a single-
chamber test may require further explanation. While both the phase 1 grooming and the 
single chamber grooming were examples of grooming time in a non-social setting, data did 
not look the same between the two measures. It should be noted that in the 3-chamber 
protocol, phase 1 grooming is measured during the first 10 minutes that the mouse has 
gained access to all three chambers of the apparatus. It is hypothesized that the resulting 
exploratory behavior diminishes grooming that is otherwise observed in the single 
chamber protocol (an environment to which the mouse has already been habituated 10 
minutes prior to timing of stereotypy). Having already exhausted exploration during 
habituation, greater grooming levels are seen in the single chamber protocol allowing for 
differences to be detected.  
Phase 2 grooming data provides different information than that given by the single 
chamber protocol because grooming during phase 2 of the 3-chamber test, the social 
setting, is often interpreted as an indicator of social anxiety. That is, a mouse is considered 
socially anxious if it grooms more during the social phase (Mines et al., 2010; McNaughton 
et al., 2008). Xuan & Hampson likewise found that while there was a trend towards 
increased grooming, neither male nor female poly(IC) mice groomed significantly more in 
the social phase of the 3-chamber test than saline controls (2014). While other literature 
regarding this particular behavioral measure could not be found, these two studies in 
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conjunction suggest that the poly(IC) mouse model may not exhibit an abnormality in this 
measure of social condition grooming. 
SOCIAL COMMUNICATION 
In this study, social communication was tested using the social transmission of food 
preference task. Our results indicated that poly(IC) mice performed this task without 
deficit. To the author's knowledge this measure has not been used to study poly(IC) mice 
with the exception of a pilot study which discovered a similar lack of deficit (Murphy, 
2014). This information contributes to the growing body of knowledge surrounding the 
behavioral phenotype of the poly(IC) mouse model of autism. Other studies that have 
assessed communication have looked at vocalizations. Schwartzer et al. found no 
abnormalities in the poly(IC) mice (2013). However, Malkova et al. (2012) found that 
poly(IC) pups, compared to controls, emit fewer ultrasonic vocalizations in response to a 
separation from their mother. Furthermore, the vocalizations are abnormal. In adults, 
Malkova et al. saw a communication deficit in male poly(IC) scent-marking in response to 
female urine. 
EFFECTS OF THE KETOGENIC DIET ON THE POLY(IC) MOUSE 
BLOOD AND WEIGHT 
 Our study found significant impacts of KD on blood and weight measurements. As 
expected, three weeks on the 6.6:1 (carbohydrates: (fats+proteins)) strict KD resulted in 
significantly increased ketone levels and significantly decreased glucose levels. 
Furthermore, poly(IC) mice on the KD did not gain weight between 5 and 8 weeks of age 
and weighed significantly less than the control diet groups at 8 weeks of age. This is 
indicative of caloric or protein restriction for the KD group. The significant difference of 
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blood ketone levels seen between males and females is not unexpected, as higher ketone 
levels in females have been well documented (Deuel et al., 1937). The reason for the 
significant difference in ketone levels of male and female poly(IC) mice on the control diet 
is unclear. However, ketone levels are overall quite low in this treatment-diet group, so the 
difference is of uncertain biological importance. 
BEHAVIOR 
Despite the unexpected results regarding our poly(IC) mice, significant and notable 
effects of KD on the poly(IC) were observed. In males, the poly(IC)-KD group was 
significantly more social in the 3-chamber test, and for both sexes, sociability in the form of 
social contact was significantly increased. Grooming in the social phase 2 of the 3-chamber 
test was significantly lower than both other groups for the male poly(IC) mice and 
significantly lower than the saline group for female poly(IC) mice. Despite the sex 
difference, KD mice had lower grooming times overall in this measure.  KD reversed 
poly(IC)-elevated grooming in the single chamber test. A diet effect was not seen in the 
marble burying task. The sex differences seen in the 3-chamber sociability and grooming 
may be a result of a less pronounced deficit in the poly(IC) mice as discussed above. 
Overall, KD increased sociability and decreased grooming time, behavioral effects 
considered beneficial in light of the core symptoms of ASD. These results are in agreement 
with previous findings that have demonstrated that KD alleviates social deficits and 
increased stereotyped behaviors in mouse models of autism. Ruskin et al. (2013) found 
that a strict KD reduced grooming in the single chamber and 3-chamber test and increased 
preference for sociability and social contact in the 3-chamber test for the BTBR mouse 
model of autism. Another study investigating the effect of KD on EL mice, a mouse model of 
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epilepsy and autism, found that strict KD improved autistic symptoms for female EL mice, 
decreasing self-directed repetitive behavior and increasing sociability within the 3-
chamber test (Fortin, 2014). The EL and BTBR mice are genetic in etiology while the 
poly(IC) is environmental. Together, these results indicate that KD may be a promising diet 
therapy for autism, both genetic and environmental in etiology. 
The mechanisms by which KD may be beneficial are relatively unknown. However, it 
is suggested that saturated fatty acids, the levels of which are raised by the diet, activate 
toll-like receptors contribute to an anti-inflammatory effect (Forsythe et al., 2008). KD also 
fundamentally alters metabolism which is often abnormal in autistic patients (Chauan et al., 
2011). Furthermore, KD increases adenosine in the brain. The promotion and reduction of 
adenosine's function is associated with the alleviation and promotion several symptoms 
and comorbidities of autism, respectively (Masino et al., 2009; Masino et al., 2011; Poon & 
Sawynok, 1999; Freitag et al., 2009; Bottini et al., 2001). Further research is needed to fully 
explore the mechanisms and applications of KD. 
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CONCLUSIONS AND FUTURE DIRECTIONS 
 This study demonstrated a clear influence of strict KD on behavior in the poly(IC) 
mice towards the improvement of sociability and alleviation of self-directed stereotyped 
behavior. While our study did not succeed in replicating several autistic behaviors in the 
poly(IC) mouse model, these effects of KD suggest that KD may be an effective diet therapy 
for autism and indicate a strong need for further research.  
In the future, research regarding the effect of KD on the autistic symptoms of the 
poly(IC) mouse model may use altered methods to elicit a clear deficit in the poly(IC) mice 
and ensure a lack of abnormality in the control group. Strategies towards this goal may 
include utilizing pups from an un-injected dam for further controls. A single injection 
procedure rather than the three injection procedure used here may reduce maternal stress 
caused by repeated handling. To assess the degree of immune response from both saline 
and poly(IC) injected dams, inflammation markers indicative of immune response may be 
monitored. Additionally, the injection of interleukin-6 (IL6) instead of poly(IC) may be 
considered. This pro-inflammatory cytokine is a critical mediator of the effect of poly(IC) 
(Smith et al., 2007). Direct injection of IL6 may reduce variability of behavior in offspring. 
Furthermore, while the sex differences seen in our data is not wholly unexpected and a 
group effect of estrus cycle should have been eliminated through the random testing of our 
procedure, monitoring estrus cycle in our female test mice may be illuminating. 
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